Overview
Carmen Barba practices practicing medicine in Florence, Italy.
Ms. Barba is highly rated in 1 condition, according to our data. Her clinical expertise encompasses West Syndrome, Early Infantile Epileptic Encephalopathy, Medium-Chain Acyl-CoA Dehydrogenase Deficiency, and Dysembryoplastic Neuroepithelial Tumors (DNET).
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Carmen Barba
Is Carmen Barba a top-rated expert for West Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Carmen Barba is classified as an Advanced expert for West Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Carmen Barba participate in research or clinical trials?
Yes. Carmen Barba has published 11 articles and abstracts on conditions like West Syndrome. You can view a list of Carmen Barba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- West SyndromeMs. Barba isAdvanced. Learn about West Syndrome.
- Experienced
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- Early Infantile Epileptic Encephalopathy
- Medium-Chain Acyl-CoA Dehydrogenase Deficiency